Results from pritelivir Phase 2 study demonstrate a favorable safety profile and a numerically higher lesion healing rate vs. foscarnetPritelivir Phase 2 results supported FDA Breakthrough Therapy ...
At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin ...
After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...
Current account recorded €12 billion surplus in August 2025, down from €30 billion in previous monthCurrent account surplus amounted to €303 billion ...
After giving some statistics, Herridge focused his opening statement to lawmakers towards the future. Like Governor Patrick ...
A meticulous study into Russian losses in Ukraine published this month by exiled Russian media outlets reports that since the ...
To assess how government transparency branding strategy affects Small and Medium Enterprises service delivery satisfaction in Bungoma County. H01a: There is no statistically significant effect of ...
Questions over the former congresswoman’s future continue to remain up in the air after Peltola left the stage to cheers and ...
Sunday Trust on MSN
How Nigeria can sustain growth, exchange rate stability'
The International Monetary Fund (IMF) had during the presentation of its World Economic Outlook report at the just concluded World Bank/IMF Annual Meetings in Washington, D.C. raised Nigeria's ...
Opinion
Opinion
The New Times on MSNWorld Statistics Day 2025: Driving change with quality statistics for everyone
Every five years, on 20th October since 2010, countries across the world come together to celebrate World Statistics Day, a moment to recognize the vital role of reliable data and quality statistics ...
Choosing a college major is an intricate balancing act between passion and practicality. However, an ever-fluctuating job ...
Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced results from the Phase III HARMONi-6 trial, conducted in China and sponsored by our partner, Akeso, Inc. (HKEX Code: 9926.HK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results